ReviewEndocrine, metabolic & immune disorders drug targets2024

miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.

Sara Anajafi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.